Cann Group Signs Strategic Partnership with Sapphire Medical

Summary

A leading Australian cannabis company, has signed a strategic partnership with UK medical cannabis distributor, Sapphire Medical on October 4, 2023. The agreement will see Cann Group supply Sapphire Medical with high-quality medical cannabis products for distribution to patients in the UK.Cann Group, a leading Australian cannabis company, has entered a strategic partnership with Sapphire Medical, a UK-based medical cannabis distributor. The agreement will enable Cann Group to supply Sapphire Medical with high-quality medical cannabis products for distribution to patients in the UK.

Key Details

• The partnership will provide Cann Group with access to the growing UK medical cannabis market, which is estimated to be worth £3 billion by 2028.
• Cann Group will supply Sapphire Medical with a range of its flower and oil products.
• The partnership will also involve collaboration on research and development of new medical cannabis products.

Significance

The partnership is a significant development for Cann Group, as it represents the company’s first foray into the UK medical cannabis market. The deal is also a major boost for Sapphire Medical, as it will give the company access to a wider range of high-quality medical cannabis products.

Industry Impact

The partnership is expected to have a positive impact on the UK medical cannabis industry. It will increase the availability of high-quality medical cannabis products for patients, and it will also encourage further research and development in the sector.

Sources

• Cann Group Signs Strategic Partnership with Sapphire Medical (Cann Group, October 4, 2023)
• Cann Group Inks Deal to Supply UK Medical Cannabis Distributor (MJBizDaily, October 4, 2023)
• Australian Cannabis Company Cann Group Partners with UK Distributor Sapphire Medical (Cannabis Business News, October 4, 2023)

You might be interested in medical cannabis, as it relates to the strategic partnership between Cann Group and Sapphire Medical. This collaboration aims to supply high-quality medical cannabis products to patients in the UK. Speaking of cannabis in Australia, Cann Group is a leading Australian cannabis company that is venturing into the UK medical cannabis market. Additionally, this partnership could contribute to the UK medical cannabis industry